1,0
4. März 2014
Mitarbeiter (anonym)
Aktueller Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Has medical in its name which will open doors to other medical companies.
Kontras
Poorly performing stock. Upper management too focused on short term gains.